1 Bio marks the next phase of growth and leadership for India

Hyderabad: The Government of Telangana today unveiled a major expansion of Genome Valley’s innovation ecosystem with the inauguration of the Telangana 1 Bio, India’s first single-use bioprocess design and scale-up facility, marking a transformative step in advancing the country’s biologics and next-generation therapeutics capabilities.

While Telangana has a deep scientific talent pool and a strong track record in vaccines and biosimilars, access to affordable and predictable scale-up infrastructure has been a long-standing bottleneck. The 1 Bio addresses this need by providing end-to-end process development and pilot-scale validation, enabling both start-ups and established companies to reduce capital investment and accelerate development timelines. For the State, it reinforces the long-term vision of positioning Genome Valley as a world-class centre for R&D-led biotech innovation and advancing India’s biologics and next-generation therapeutics capabilities.

1 Bio, conceptualised by the Government of Telangana through Telangana Lifesciences in collaboration with the Department of Biotechnology (DBT), Government of India, and the Telangana Industrial Infrastructure Corporation (TGIIC), is being built on a 2-acre campus at Genome Valley. At its core, the hub features a state-of-the-art single-use bioprocess development and scale-up facility, with bioreactors up to 500 L, advanced upstream and downstream systems, and a dedicated analytical suite. Developed in partnership with Thermo Fisher Scientific, a Fortune 500 global leader, this Bioprocess Design Centre positions Telangana at the forefront of GLP- and GMP-grade biomolecule development for India and the world in advancing next-generation capabilities essential for India’s growing biologics pipeline. Supporting this infrastructure, 1 Bio  houses 150,000 sq. ft. of plug-and-play R&D labs, configurable innovation suites, shared analytical spaces equipped with advanced analytical systems, and dedicated bioprocess training labs, offering a fully integrated ecosystem for end-to-end biopharma development.

The occasion also commemorated 25 years of Genome Valley, with Hon’ble Minister Shri D. Sridhar Babu unveiling a new Genome Valley logo that signifies the cluster’s transformation into a leading global centre for research-driven biotech innovation. The Minister further revealed the design for a landmark gateway structure to be built at the entry of Genome Valley along the State Highway, reinforcing the cluster’s identity and global positioning.

To support the cluster’s next phase of expansion, the Minister announced more than Rs. 200 crore worth of infrastructure upgrades to be undertaken by the Telangana Industrial Infrastructure and Investment Corporation (TGIIC). These include road widening, new greenfield roads, power augmentation, landscaping and streetscaping improvements, and other critical upgrades that enhance connectivity, utility reliability, and overall quality of life within the cluster.

The State, through an innovative PPP model, has enabled investment of Rs. 150 crores in core infrastructure, while Thermo Fisher has contributed Rs. 90 crores towards the Bioprocess Design Centre and its co-located Customer Experience Centre within Genome Valley. 1 Bio is expected to attract an additional Rs. 500 crores in private investment from tenant companies and create over 500 high-quality jobs.

1 Bio was officially inaugurated by Hon’ble Minister Shri D. Sridhar Babu, in the presence of senior leaders from the Indian and Telangana life sciences industry, as well as senior officials from the Government of Telangana. Mr Fred Lowery, Executive Vice President of Thermo Fisher Scientific, along with the company’s global leadership team, joined the Minister to inaugurate both the Bioprocess Design Centre at 1 Bio and Thermo Fisher’s Customer Experience Centre.

Speaking on the occasion, Hon’ble Minister for IT, Electronics & Communications, and Industries & Commerce, Government of Telangana, Shri D. Sridhar Babu, said, “As Genome Valley marks 25 years, we are setting the course for its next 25. 1 Bio is one of India’s most important steps toward democratizing access to biologics scale-up and accelerating the journey from discovery to clinical readiness. With this facility, innovations developed in India or anywhere in the world can now progress to pilot and clinical stages in Hyderabad faster, more predictably, and at lower cost. Alongside the new identity for Genome Valley, the gateway structure, and over Rs. 200 crores in planned infrastructure upgrades, we are preparing this cluster for its next wave of global leadership in the life sciences”. 

Mr. Sanjay Kumar, IAS, Special Chief Secretary, Industries & Commerce and ITE&C Departments, Government of Telangana, said, “Telangana continues to lead the country’s life sciences growth story, accounting for 40% of its pharma production and a third of global vaccine production. 1 Bio adds an important dimension by giving innovators access to world-class bioprocess development and scale-up capacity within the State.”

Mr Shakthi M. Nagappan, CEO, Telangana Life Sciences Foundation, added, “1 Bio  fills one of the most critical missing links in India’s biologics ecosystem. Start-ups and established companies can now use this shared facility to validate processes, generate pilot data, and build confidence in manufacturability without heavy upfront investments. By providing world-class bioprocess development capability inside Genome Valley in partnership with Thermofisher, we are strengthening the pathway from research to real-world products.”

Tony Acciarito, President, Asia Pacific and Middle East, Africa Thermo Fisher Scientific, said, “India’s life sciences sector is at an inflection point. These new centres reinforce our commitment to supporting the region’s growth through meaningful collaborations that help researchers and industry partners move from ideas to impact faster.”

Srinath Venkatesh, Managing Director, India and South Asia, Thermo Fisher Scientific, added, “We are committed to enabling a sustainable ecosystem that integrates talent, infrastructure, and cutting-edge technology, strengthening India’s position on the global biopharma and life sciences stage. Expanding our capability footprint through these centres demonstrates our vision to be the preferred partner for innovation, development, and manufacturing within the country.”

The post Minister Sridhar Babu unveils the Next Wave of Growth for Genome Valley appeared first on newsmantra.in l Latest news on Politics, World, Bollywood, Sports, Delhi, Jammu & Kashmir, Trending news | News Mantra.

Hyderabad, November 24, 2025: The Government of Telangana today unveiled a major expansion of Genome Valley’s innovation ecosystem with the inauguration of the Telangana 1 Bio, India’s first single-use bioprocess design and scale-up facility, marking a transformative step in advancing the country’s biologics and next-generation therapeutics capabilities.

While Telangana has a deep scientific talent pool and a strong track record in vaccines and biosimilars, access to affordable and predictable scale-up infrastructure has been a long-standing bottleneck. The 1 Bio addresses this need by providing end-to-end process development and pilot-scale validation, enabling both start-ups and established companies to reduce capital investment and accelerate development timelines. For the State, it reinforces the long-term vision of positioning Genome Valley as a world-class centre for R&D-led biotech innovation and advancing India’s biologics and next-generation therapeutics capabilities.

1 Bio, conceptualised by the Government of Telangana through Telangana Lifesciences in collaboration with the Department of Biotechnology (DBT), Government of India, and the Telangana Industrial Infrastructure Corporation (TGIIC), is being built on a 2-acre campus at Genome Valley. At its core, the hub features a state-of-the-art single-use bioprocess development and scale-up facility, with bioreactors up to 500 L, advanced upstream and downstream systems, and a dedicated analytical suite. Developed in partnership with Thermo Fisher Scientific, a Fortune 500 global leader, this Bioprocess Design Centre positions Telangana at the forefront of GLP- and GMP-grade biomolecule development for India and the world in advancing next-generation capabilities essential for India’s growing biologics pipeline. Supporting this infrastructure, 1 Bio  houses 150,000 sq. ft. of plug-and-play R&D labs, configurable innovation suites, shared analytical spaces equipped with advanced analytical systems, and dedicated bioprocess training labs, offering a fully integrated ecosystem for end-to-end biopharma development.

The occasion also commemorated 25 years of Genome Valley, with Hon’ble Minister Shri D. Sridhar Babu unveiling a new Genome Valley logo that signifies the cluster’s transformation into a leading global centre for research-driven biotech innovation. The Minister further revealed the design for a landmark gateway structure to be built at the entry of Genome Valley along the State Highway, reinforcing the cluster’s identity and global positioning.

To support the cluster’s next phase of expansion, the Minister announced more than Rs. 200 crore worth of infrastructure upgrades to be undertaken by the Telangana Industrial Infrastructure and Investment Corporation (TGIIC). These include road widening, new greenfield roads, power augmentation, landscaping and streetscaping improvements, and other critical upgrades that enhance connectivity, utility reliability, and overall quality of life within the cluster.

The State, through an innovative PPP model, has enabled investment of Rs. 150 crores in core infrastructure, while Thermo Fisher has contributed Rs. 90 crores towards the Bioprocess Design Centre and its co-located Customer Experience Centre within Genome Valley. 1 Bio is expected to attract an additional Rs. 500 crores in private investment from tenant companies and create over 500 high-quality jobs.

1 Bio was officially inaugurated by Hon’ble Minister Shri D. Sridhar Babu, in the presence of senior leaders from the Indian and Telangana life sciences industry, as well as senior officials from the Government of Telangana. Mr Fred Lowery, Executive Vice President of Thermo Fisher Scientific, along with the company’s global leadership team, joined the Minister to inaugurate both the Bioprocess Design Centre at 1 Bio and Thermo Fisher’s Customer Experience Centre.

Speaking on the occasion, Hon’ble Minister for IT, Electronics & Communications, and Industries & Commerce, Government of Telangana, Shri D. Sridhar Babu, said, “As Genome Valley marks 25 years, we are setting the course for its next 25. 1 Bio is one of India’s most important steps toward democratizing access to biologics scale-up and accelerating the journey from discovery to clinical readiness. With this facility, innovations developed in India or anywhere in the world can now progress to pilot and clinical stages in Hyderabad faster, more predictably, and at lower cost. Alongside the new identity for Genome Valley, the gateway structure, and over Rs. 200 crores in planned infrastructure upgrades, we are preparing this cluster for its next wave of global leadership in the life sciences”. 

Mr. Sanjay Kumar, IAS, Special Chief Secretary, Industries & Commerce and ITE&C Departments, Government of Telangana, said, “Telangana continues to lead the country’s life sciences growth story, accounting for 40% of its pharma production and a third of global vaccine production. 1 Bio adds an important dimension by giving innovators access to world-class bioprocess development and scale-up capacity within the State.”

Mr Shakthi M. Nagappan, CEO, Telangana Life Sciences Foundation, added, “1 Bio  fills one of the most critical missing links in India’s biologics ecosystem. Start-ups and established companies can now use this shared facility to validate processes, generate pilot data, and build confidence in manufacturability without heavy upfront investments. By providing world-class bioprocess development capability inside Genome Valley in partnership with Thermofisher, we are strengthening the pathway from research to real-world products.”

Tony Acciarito, President, Asia Pacific and Middle East, Africa Thermo Fisher Scientific, said, “India’s life sciences sector is at an inflection point. These new centres reinforce our commitment to supporting the region’s growth through meaningful collaborations that help researchers and industry partners move from ideas to impact faster.”

Srinath Venkatesh, Managing Director, India and South Asia, Thermo Fisher Scientific, added, “We are committed to enabling a sustainable ecosystem that integrates talent, infrastructure, and cutting-edge technology, strengthening India’s position on the global biopharma and life sciences stage. Expanding our capability footprint through these centres demonstrates our vision to be the preferred partner for innovation, development, and manufacturing within the country.”

The post Minister Sridhar Babu unveils the Next Wave of Growth for Genome Valley; Inaugurates Nation’s First logical Single-Use Scale-Up Facility – 1 Bio appeared first on newsmantra.in l Latest news on Politics, World, Bollywood, Sports, Delhi, Jammu & Kashmir, Trending news | News Mantra.

Bio Asia 2025 themed ‘Catalysts of Change – Expanding Global Healthcare Frontiers, Transforming Healthcare with Innovation, Collaboration and Progress’, the marque life sciences and healthcare conferences in the country has a power-packed agenda comprising of address from Mr. A Revanth Reddy, Hon’ble CM of Telangana, Dr. Jeannette Young, Hon’ble Governor of Queensland, Mr. Amitabh Kant, G20 Sherpa, Mr. Piyush Goyal, Hon’ble Minister of Industry and Supplies, Govt. of India, besides the global Industry leaders will be the highlight of Bio Asia 2025. 

Bio Asia 2025 will initiate intense deliberations on the latest developments, opportunities, and challenges in the life sciences space. Notable industry leaders from leading global organizations like Robert A. Bradway (Chairman & CEO, Amgen), Prof. Patrick Tan, (Executive Director, Genome Institute of Singapore), Dr. Ken Washington (CTO, Medtronic), Dr. Boris Stoffel (Managing Director, Miltenyi Biotec) along with leaders from other global healthcare organizations will participate across 8 sessions and the CEO Conclave scheduled on 25^th and 26^th February 2025. A detailed schedule for Bio Asia 2025 can be accessed here.

Mr. Sridhar Babu, Minister for Industries and Commerce, Government of Telangana, said: “As a part of BioAsia 2025 we are delighted to showcase the premier life sciences research and manufacturing clusters to the national and international delegates today. The next 2 days will have an exceptional speaker lineup, with a strong focus on AI and life sciences, making it the biggest and most impactful BioAsia in history.“

Mr. Jayesh Ranjan IAS, Special Chief Secretary, Industries & Commerce and Information Technology, Government of Telangana, said: ” We are delighted to showcase Telangana’s thriving life sciences and healthcare clusters to national and international delegates at BioAsia 2025. We look forward to two days of insightful deliberations with a distinguished lineup of speakers, fostering forward-looking perspectives that will drive the sector’s growth and innovation.”

Mr. Shakthi Nagappan, CEO of BioAsia and Director of Telangana Life Sciences, emphasized “Telangana continues to lead the convergence of life sciences and technology. BioAsia 2025 is set to be a landmark edition with several global leaders participating in the event. Today’s visit by delegates to the Life Sciences clusters in the state and the visit to key facilities would have given them insights into the robust life sciences eco system in the state.”

BioAsia has consistently drawn global attention, with leading corporations and industry stakeholders actively contributing to India’s emergence as a hub for innovation in biotechnology, pharmaceuticals, medical technology, and healthcare. Over the years, the conference has hosted influential figures, including Nobel Laureates, Lasker Awardees, and global leaders such as Bill Gates (Gates Foundation), Satya Nadella (Microsoft), Alex Gorsky (Johnson & Johnson), Dr. Vas Narasimhan (Novartis), and Geoff Martha (Medtronic).

The post BioAsia 2025- Bio Park visit highlights significant advancements of Telangana in Lifesciences sector appeared first on newsmantra.in l Latest news on Politics, World, Bollywood, Sports, Delhi, Jammu & Kashmir, Trending news | News Mantra.